OpenVSafe by OpenVAERS
Search V-safe

AAX-21112-93185

4 vaccinations 11 coded responses 44 check-ins 10 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
271 / NC
Registered
2021-03-02
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-02
    Registered in v-safe
  2. 2021-03-02
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-02
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  4. 2021-03-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Condition aggravated, Neuropathy peripheral — Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: I have neuropathy in my extremities; it seemed to be a little mire active today than usual, more discomfort in both hands and feet.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Discomfort — Feeling: Good · Fatigue or tiredness
    Free text: There is still some increase in the discomfort I feel in my extremities, as reported yesterday, but it is not as marked today.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: Good · Fever · Chills, Joint pains, Muscle or body aches
    Free text: Again today, my neuropathy discomfort was more noticeable than in the past several weeks, especially in my feet and ankles.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Neuropathy peripheral — Feeling: Good · Headache, Fatigue or tiredness
    Free text: Continued MILD symptoms associated with neuropathy.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-09
    Survey response — day 7, dose 1
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Fatigue or tiredness
    Free text: Neuropathy discomfort still somewhat increased.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-16
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  10. 2021-03-24
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-29
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event, Unevaluable event — Feeling: Good · Site: Pain
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  16. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-04-05
    Survey response — day 7, dose 2
    MedDRA: Insomnia — Feeling: Good
    Free text: Slept very poorly.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-09-27
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-10-03
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  26. 2021-10-03
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Neuropathy seems more marked than usual.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Headache, Nausea, Diarrhea
    Adult check-in
  29. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  30. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  31. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  32. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  33. 2021-10-10
    Health check-in — day 7, dose 3
    Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  34. 2021-10-17
    Health check-in — day 14, dose 3
    Feeling: Poor
    Adult check-in
  35. 2021-10-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-31
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-02
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  40. 2022-04-03
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  41. 2022-04-05
    Dose 4 — Pfizer-BioNTech
  42. 2022-04-19
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-04-26
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  44. 2022-05-03
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-05-10
    Survey response — day 35, dose 4
    MedDRA: Pre-existing disease, Psoriasis — Feeling: Good
    Free text: Flare-up of my psoriasis.
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-17
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  47. 2022-07-05
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-10-08
    Survey response — 6 months, dose 4
    MedDRA: Asthenia, Guillain-Barre syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Generalized weakness, diagnosed as mild Guillain-Barr.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-10-08
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  50. 2022-10-10
  51. 2023-04-05
    Survey response — 12 months, dose 4
    MedDRA: Deafness unilateral, Heart rate irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  52. 2023-04-05
    Report sent to call center — 12 months, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  53. 2023-04-06
  54. 2023-04-06

Vaccinations

DoseDateManufacturerCo-administered
12021-03-02Pfizer-BioNTech
22021-03-29Pfizer-BioNTech
32021-10-03Pfizer-BioNTech Flu
42022-04-05Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-03

Systemic reaction (other): I have neuropathy in my extremities; it seemed to be a little mire active today than usual, more discomfort in both hands and feet.

2021-03-04

Systemic reaction (other): There is still some increase in the discomfort I feel in my extremities, as reported yesterday, but it is not as marked today.

2021-03-05

Systemic reaction (other): Again today, my neuropathy discomfort was more noticeable than in the past several weeks, especially in my feet and ankles.

2021-03-07

Systemic reaction (other): Continued MILD symptoms associated with neuropathy.

Release 5 — day 7, dose 1

2021-03-09

Systemic reaction (other): Neuropathy discomfort still somewhat increased.

Release 6 — days 1–6 daily, dose 2

2021-03-30

Systemic reaction (other): None

Release 6 — day 7, dose 2

2021-04-05

Systemic reaction (other): Slept very poorly.

Release 9 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Neuropathy seems more marked than usual.

Release 11 — day 35, dose 4

2022-05-10

Symptoms: Flare-up of my psoriasis.

Release 12 — 6 months, dose 4

2022-10-08

Symptoms: Generalized weakness, diagnosed as mild Guillain-Barr.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia · · ✓
SDDeafness unilateral · · ✓
SDGuillain-Barre syndrome · · ✓
SDHeart rate irregular · · ✓
SDPre-existing disease · · ✓
SDPsoriasis · · ✓
SROCondition aggravated ✓ ✓ ✓
SRODiscomfort ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓
SRONeuropathy peripheral ✓ ✓ ✓
SRONo adverse event ✓ · ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ○ ✓ ○

✓ active code · ○ coded but marked inactive · blank = not in that release